Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study.

Shusterman S, Naranjo A, Van Ryn C, Hank JA, Parisi MT, Shulkin BL, Servaes S, London WB, Shimada H, Gan J, Gillies SD, Maris JM, Park JR, Sondel PM.

Clin Cancer Res. 2019 Jul 29. doi: 10.1158/1078-0432.CCR-19-0798. [Epub ahead of print]

PMID:
31358541
2.

Evaluation of the utility of 99m Tc-MDP bone scintigraphy versus MIBG scintigraphy and cross-sectional imaging for staging patients with neuroblastoma.

Gauguet JM, Pace-Emerson T, Grant FD, Shusterman S, DuBois SG, Frazier AL, Voss SD.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26601. Epub 2017 Apr 27.

PMID:
28449267
3.

A Comparison of Mixed Dentition Dental Development in Cleft Patients Treated With and Without the Latham-type Appliance.

Lin J, Allareddy V, Ross E, Shusterman S.

Pediatr Dent. 2017 Jan 15;39(1):53-58.

PMID:
28292342
4.

Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation.

Li R, Polishchuk A, DuBois S, Hawkins R, Lee SW, Bagatell R, Shusterman S, Hill-Kayser C, Al-Sayegh H, Diller L, Haas-Kogan DA, Matthay KK, London WB, Marcus KJ.

Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):270-277. doi: 10.1016/j.ijrobp.2016.10.047. Epub 2016 Nov 8.

PMID:
28068235
5.

Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study.

Harris MH, DuBois SG, Glade Bender JL, Kim A, Crompton BD, Parker E, Dumont IP, Hong AL, Guo D, Church A, Stegmaier K, Roberts CWM, Shusterman S, London WB, MacConaill LE, Lindeman NI, Diller L, Rodriguez-Galindo C, Janeway KA.

JAMA Oncol. 2016 May 1;2(5):608-615. doi: 10.1001/jamaoncol.2015.5689.

PMID:
26822149
6.

Clinician's Primer to ICD-10-CM Coding for Cleft Lip/Palate Care.

Allori AC, Cragan JD, Della Porta GC, Mulliken JB, Meara JG, Bruun R, Shusterman S, Cassell CH, Raynor E, Santiago P, Marcus JR.

Cleft Palate Craniofac J. 2017 Jan;54(1):e7-e13. doi: 10.1597/15-219. Epub 2015 Nov 2.

PMID:
26523325
7.

Classification of Cleft Lip/Palate: Then and Now.

Allori AC, Mulliken JB, Meara JG, Shusterman S, Marcus JR.

Cleft Palate Craniofac J. 2017 Mar;54(2):175-188. doi: 10.1597/14-080. Epub 2015 Sep 4.

PMID:
26339868
8.

Effect of infant surgical orthopedic treatment on facial growth in preadolescent children with unilateral and bilateral complete cleft lip and palate.

Tan SP, Allareddy V, Bruun RA, Mulliken JB, Sullivan SR, Peguero OJ Jr, Cooper JS, Padwa BL, Gerlein EJ, Cook EF, Shusterman S.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Sep;120(3):291-8. doi: 10.1016/j.oooo.2015.04.016. Epub 2015 Jun 9.

PMID:
26297388
9.

A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma.

Krishnadas DK, Shusterman S, Bai F, Diller L, Sullivan JE, Cheerva AC, George RE, Lucas KG.

Cancer Immunol Immunother. 2015 Oct;64(10):1251-60. doi: 10.1007/s00262-015-1731-3. Epub 2015 Jun 24.

PMID:
26105625
10.

Assessment of morbidity following insertion of fixed preoperative orthopedic appliance in infants with complete cleft lip and palate.

Bronkhorst A, Allareddy V, Allred E, Ross E, Shusterman S.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Mar;119(3):278-84. doi: 10.1016/j.oooo.2014.11.011. Epub 2014 Dec 4.

PMID:
25592867
11.

Operative and Immediate Postoperative Outcomes of Using a Latham-Type Dentomaxillary Appliance in Patients With Unilateral Complete Cleft Lip and Palate.

Allareddy V, Ross E, Bruun R, Lee MK, Shusterman S.

Cleft Palate Craniofac J. 2015 Jul;52(4):405-10. doi: 10.1597/13-294. Epub 2014 Jul 24.

PMID:
25058119
12.

Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors.

Norris RE, Shusterman S, Gore L, Muscal JA, Macy ME, Fox E, Berkowitz N, Buchbinder A, Bagatell R.

Pediatr Blood Cancer. 2014 Oct;61(10):1792-7. doi: 10.1002/pbc.25105. Epub 2014 Jun 24.

PMID:
24962521
13.

Neuroblastoma presenting as facial nerve palsy and bulging tympanic membrane.

Bernson-Leung M, Ananth P, Shusterman S.

Clin Pediatr (Phila). 2015 Feb;54(2):183-5. doi: 10.1177/0009922814534314. Epub 2014 May 9. No abstract available.

PMID:
24817076
14.

Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621).

Fox E, Mosse' YP, Meany HM, Gurney JG, Khanna G, Jackson HA, Gordon G, Shusterman S, Park JR, Cohn SL, Adamson PC, London WB, Maris JM, Balis FM.

Pediatr Blood Cancer. 2014 Jun;61(6):990-6. doi: 10.1002/pbc.24900. Epub 2013 Dec 18.

15.

Radiation exposure to family caregivers and nurses of pediatric neuroblastoma patients receiving 131I-metaiodobenzylguanidine (131I-MIBG) therapy.

Markelewicz RJ Jr, Lorenzen WA, Shusterman S, Grant FD, Fahey FH, Treves ST.

Clin Nucl Med. 2013 Aug;38(8):604-7. doi: 10.1097/RLU.0b013e31829af3c8.

PMID:
23797228
16.

FaceReview: supporting interactive exploration of linked heterogeneous datasets for unilateral cleft lip and palate.

Lee S, Kim B, Lee B, Kim B, Han B, Anderson NK, Bruun RA, Shusterman S, Seo J.

AMIA Annu Symp Proc. 2012;2012:485-94. Epub 2012 Nov 3.

17.

Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastoma.

Grupp SA, Prak EL, Boyer J, McDonald KR, Shusterman S, Thompson E, Callahan C, Jawad AF, Levine BL, June CH, Sullivan KE.

Clin Cancer Res. 2012 Dec 15;18(24):6732-41. doi: 10.1158/1078-0432.CCR-12-1432. Epub 2012 Oct 23. Erratum in: Clin Cancer Res. 2017 Feb 1;23 (3):869.

18.

Surface x-ray diffraction results on the III-V droplet heteroepitaxy growth process for quantum dots: recent understanding and open questions.

Cohen E, Elfassy N, Koplovitz G, Yochelis S, Shusterman S, Kumah DP, Yacoby Y, Clarke R, Paltiel Y.

Sensors (Basel). 2011;11(11):10624-37. doi: 10.3390/s111110624. Epub 2011 Nov 8.

19.

Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group study.

DuBois SG, Shusterman S, Reid JM, Ingle AM, Ahern CH, Baruchel S, Glade-Bender J, Ivy P, Adamson PC, Blaney SM.

Cancer Chemother Pharmacol. 2012 Apr;69(4):1021-7. doi: 10.1007/s00280-011-1798-2. Epub 2011 Dec 18.

20.

Iodine-131-labeled meta-iodobenzylguanidine therapy of children with neuroblastoma: program planning and initial experience.

Shusterman S, Grant FD, Lorenzen W, Davis RT, Laffin S, Drubach LA, Fahey FH, Treves ST.

Semin Nucl Med. 2011 Sep;41(5):354-63. doi: 10.1053/j.semnuclmed.2011.06.001. Review.

PMID:
21803185
21.

Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study.

Dubois SG, Shusterman S, Ingle AM, Ahern CH, Reid JM, Wu B, Baruchel S, Glade-Bender J, Ivy P, Grier HE, Adamson PC, Blaney SM.

Clin Cancer Res. 2011 Aug 1;17(15):5113-22. doi: 10.1158/1078-0432.CCR-11-0237. Epub 2011 Jun 20.

22.

Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.

Minturn JE, Evans AE, Villablanca JG, Yanik GA, Park JR, Shusterman S, Groshen S, Hellriegel ET, Bensen-Kennedy D, Matthay KK, Brodeur GM, Maris JM.

Cancer Chemother Pharmacol. 2011 Oct;68(4):1057-65. doi: 10.1007/s00280-011-1581-4. Epub 2011 Feb 22.

23.

Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium.

Aplenc R, Blaney SM, Strauss LC, Balis FM, Shusterman S, Ingle AM, Agrawal S, Sun J, Wright JJ, Adamson PC.

J Clin Oncol. 2011 Mar 1;29(7):839-44. doi: 10.1200/JCO.2010.30.7231. Epub 2011 Jan 24.

24.

Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.

Delgado DC, Hank JA, Kolesar J, Lorentzen D, Gan J, Seo S, Kim K, Shusterman S, Gillies SD, Reisfeld RA, Yang R, Gadbaw B, DeSantes KB, London WB, Seeger RC, Maris JM, Sondel PM.

Cancer Res. 2010 Dec 1;70(23):9554-61. doi: 10.1158/0008-5472.CAN-10-2211. Epub 2010 Oct 8.

25.

Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study.

Shusterman S, London WB, Gillies SD, Hank JA, Voss SD, Seeger RC, Reynolds CP, Kimball J, Albertini MR, Wagner B, Gan J, Eickhoff J, DeSantes KB, Cohn SL, Hecht T, Gadbaw B, Reisfeld RA, Maris JM, Sondel PM.

J Clin Oncol. 2010 Nov 20;28(33):4969-75. doi: 10.1200/JCO.2009.27.8861. Epub 2010 Oct 4.

26.

Efficient second-harmonic generation and modal dispersion effects in orientation-patterned GaAs waveguides.

Oron MB, Pearl S, Blau P, Shusterman S.

Opt Lett. 2010 Aug 15;35(16):2678-80. doi: 10.1364/OL.35.002678.

PMID:
20717421
27.

Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl.

Lodish MB, Adams KT, Huynh TT, Prodanov T, Ling A, Chen C, Shusterman S, Jimenez C, Merino M, Hughes M, Cradic KW, Milosevic D, Singh RJ, Stratakis CA, Pacak K.

Endocr Relat Cancer. 2010 Jun 3;17(3):581-8. doi: 10.1677/ERC-10-0004. Print 2010 Sep.

28.

Atomic-scale mapping of quantum dots formed by droplet epitaxy.

Kumah DP, Shusterman S, Paltiel Y, Yacoby Y, Clarke R.

Nat Nanotechnol. 2009 Dec;4(12):835-8. doi: 10.1038/nnano.2009.271. Epub 2009 Sep 27.

PMID:
19893522
29.

Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.

Matthay KK, Quach A, Huberty J, Franc BL, Hawkins RA, Jackson H, Groshen S, Shusterman S, Yanik G, Veatch J, Brophy P, Villablanca JG, Maris JM.

J Clin Oncol. 2009 Mar 1;27(7):1020-5. doi: 10.1200/JCO.2007.15.7628. Epub 2009 Jan 26.

30.

Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.

Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, Shue D, Seiser E, Jagannathan J, Shusterman S, Bansal M, Khazi D, Winter C, Okawa E, Grant G, Cnaan A, Zhao H, Cheung NK, Gerald W, London W, Matthay KK, Brodeur GM, Maris JM.

Cancer Res. 2006 Jun 15;66(12):6050-62.

31.

Prospects for therapeutic inhibition of neuroblastoma angiogenesis.

Shusterman S, Maris JM.

Cancer Lett. 2005 Oct 18;228(1-2):171-9. Review.

PMID:
15927358
32.

Methionine aminopeptidase 2 inhibition is an effective treatment strategy for neuroblastoma in preclinical models.

Morowitz MJ, Barr R, Wang Q, King R, Rhodin N, Pawel B, Zhao H, Erickson SA, Sheppard GS, Wang J, Maris JM, Shusterman S.

Clin Cancer Res. 2005 Apr 1;11(7):2680-5.

33.

Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reaction.

Morowitz M, Shusterman S, Mosse Y, Hii G, Winter CL, Khazi D, Wang Q, King R, Maris JM.

Mod Pathol. 2003 Dec;16(12):1248-56.

34.

Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.

Wang J, Sheppard GS, Lou P, Kawai M, BaMaung N, Erickson SA, Tucker-Garcia L, Park C, Bouska J, Wang YC, Frost D, Tapang P, Albert DH, Morgan SJ, Morowitz M, Shusterman S, Maris JM, Lesniewski R, Henkin J.

Cancer Res. 2003 Nov 15;63(22):7861-9.

35.

The effects of active infant orthopedics on occlusal relationships in unilateral complete cleft lip and palate.

Chan KT, Hayes C, Shusterman S, Mulliken JB, Will LA.

Cleft Palate Craniofac J. 2003 Sep;40(5):511-7.

PMID:
12943436
36.

ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.

Wang Q, Hii G, Shusterman S, Mosse Y, Winter CL, Guo C, Zhao H, Rappaport E, Hogarty MD, Maris JM.

Cancer Res. 2003 Apr 1;63(7):1631-5.

37.

Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13.

Maris JM, Weiss MJ, Mosse Y, Hii G, Guo C, White PS, Hogarty MD, Mirensky T, Brodeur GM, Rebbeck TR, Urbanek M, Shusterman S.

Cancer Res. 2002 Nov 15;62(22):6651-8.

38.

Year one dental visit.

Doykos JD 3rd, Goldberg N, Sonis AL, Hertzberg J, Frank RA, McBride S, Shusterman S, Morgan L, Needleman H, Nelson LP, Bruun R, Giffith DG, Geller P, Morell M.

Pediatr Dent. 2001 May-Jun;23(3):195, 197. No abstract available.

PMID:
11447947
39.

Angiogenesis inhibitor TNP-470 during bone marrow transplant: safety in a preclinical model.

Stern JW, Fang J, Shusterman S, Pierson G, Barr R, Pawel B, Diller L, Grupp SA.

Clin Cancer Res. 2001 Apr;7(4):1026-32.

40.

The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease.

Shusterman S, Grupp SA, Barr R, Carpentieri D, Zhao H, Maris JM.

Clin Cancer Res. 2001 Apr;7(4):977-84.

41.

Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470.

Shusterman S, Grupp SA, Maris JM.

Med Pediatr Oncol. 2000 Dec;35(6):673-6.

PMID:
11107144
42.

Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13.

Weiss MJ, Guo C, Shusterman S, Hii G, Mirensky TL, White PS, Hogarty MD, Rebbeck TR, Teare D, Urbanek M, Brodeur GM, Maris JM.

Med Pediatr Oncol. 2000 Dec;35(6):526-30.

PMID:
11107108
43.

Long term survivors of childhood leukemia.

Shusterman S, Meadows AT.

Curr Opin Hematol. 2000 Jul;7(4):217-22. Review.

PMID:
10882177
44.

Microbiological findings in prepubertal periodontitis. A case report.

Dibart S, Chapple IL, Skobe Z, Shusterman S, Nedleman HL.

J Periodontol. 1998 Oct;69(10):1172-5.

PMID:
9802719
45.

Delayed dental maturation in cleidocranial dysplasia.

Shaikh R, Shusterman S.

ASDC J Dent Child. 1998 Sep-Oct;65(5):325-9, 355.

PMID:
9795736
46.

Morphometric analysis of the primary and permanent dentitions in hemifacial microsomia: a controlled study.

Seow WK, Urban S, Vafaie N, Shusterman S.

J Dent Res. 1998 Jan;77(1):27-38.

PMID:
9437397
47.

Emergency management of oral trauma in children.

Nelson LP, Shusterman S.

Curr Opin Pediatr. 1997 Jun;9(3):242-5. Review.

PMID:
9229163
48.

Developmental dental changes in isolated cleft lip and palate.

Pham AN, Seow WK, Shusterman S.

Pediatr Dent. 1997 Mar-Apr;19(2):109-13.

PMID:
9106872
49.

A 2.5-month-old girl with hyperbilirubinemia, hypoglycemia, and blindness.

Shusterman S, Palmert MR.

Curr Opin Pediatr. 1996 Aug;8(4):411-6. No abstract available.

PMID:
8954277
50.

Custom oral appliance for noninvasive immobilization during stereotactic radiotherapy.

Havelka C, Nelson LP, Shusterman S, Bellerive M.

Pediatr Dent. 1995 May-Jun;17(3):212-5. No abstract available.

PMID:
7617498

Supplemental Content

Loading ...
Support Center